Navigation Links
International liver cancer congress provides possible solutions to reduce significant burden
Date:6/25/2010

Geneva, Switzerland, Friday, 25 June 2010: Today, world renowned experts have assembled in Dubrovnik, Croatia to discuss the latest trends in treatment and cutting edge research in diagnostic techniques that will shape the future management of hepatocellular carcinoma (HCC) the third most common cause of cancer-related death globally, and a leading cause of death among patients with liver cirrhosis.

"This HCC conference is a significant milestone in the field of HCC research. We are encouraged by the range of topics and eminent researchers in attendance, bringing new understanding and celebrating new research opportunities from across the world that will help address the current challenges we face as clinicians. This ultimately will help drive our ultimate goal of reducing the suffering caused by this devastating and debilitating disease," commented Professor Josep M Llovet, chair of the HCC special conference and Professor of Research, Liver Unit, Hospital Clnic, Barcelona, Spain and Professor of Medicine, Director, Mount Sinai Liver Cancer Research Program, Mount Sinai School of Medicine, New York.

At the two-day conference, entitled: Hepatocellular Carcinoma from genomics to treatment, organised by the European Association for the Study of the Liver (EASL), experts will address a range of key topics, including: the genetic make-up of HCC, the molecular signatures and biomarkers and other advancements to determine diagnosis and prognosis of HCC, and potential disease targets to develop new treatment strategies. Specifically, several novel molecular targeted therapies are currently being tested in advanced stages of clinical research, and their results expected by 2011-14 might improve the standard of care of patients suffering this neoplasm.

HCC is a cancer originating in liver cells and is one of the most common types of tumour. Worldwide, HCC accounts for approximately 5.4% of all cancers3 and causes 610,000 deaths per year. It is the fifth most common cause of cancer in men and the eighth most common cause in women. HCC is the most common cancer in Sub-Saharan Africa and Southeast Asia mainly due to the high rates of HCV and HBV infection. In western countries, alcoholism and viral hepatitis are the leading causes of cirrhosis and subsequent HCC.

The HCC conference is supported by leading professional organisations across the world, including the American Association for the Study of Liver Diseases (AASLD), the Asian Pacific Association for Study of the Liver (APASL) and the Latin-American for the Study of the Liver (ALEH).

"EASL is dedicated to promoting research and education in the field of hepatology to improve the treatment of liver disease throughout the world. In bringing experts together at this first-ever medical conference on HCC we aim to promote the latest evidence base and best practise to address this significant global killer disease," added Professor Heiner Wedemeyer, EASL Secretary General.

In line with the importance of the meeting, EASL would like to inform its members and the conference delegates that the European Commission Seventh Framework Programme (FP7-Health 2010) has funded the HEPTROMIC project, a 3-year translational research initiative on liver cancer. This network, aimed at solving molecular and technological challenges, constitutes the first European research project specifically focused on genomics in HCC funded by the European Union. With the final negotiations with the European Commission well underway, HEPTROMIC is currently gearing up to become a decisive modern cooperative and multidisciplinary effort in the fight against this cancer. Led from the Institut d'Investigacions Biomdiques August Pi i Sunyer (IDIBAPS) - Hospital Clnic of Barcelona (Spain), this initiative combines the knowhow of six leading research groups in Europe and the USA and two companies, to ensure the translation of research results into new prognostic tests and devices.


'/>"/>

Contact: Isabelle Scali
media.easl2010@cohnwolfe.com
44-771-743-5103
European Association for the Study of the Liver
Source:Eurekalert

Related medicine news :

1. Royal Caribbean International and LimoRes.com Announce Exclusive Partnership
2. Global Aids Alliance Celebrates the Introduction of the International Violence Against Women Act, Urges Swift Passage
3. International Pelvic Floor Muscle Expert Presents Live Webinars on Telemedecine
4. Ganeden Biotech and Pathway International Announce Exclusive Distribution Partnership
5. Luis Tiant and Sunridge International Partner to Provide Medical Relief in Cuba: Former Star Pitcher for the Red Sox and Yankees Leads the Fight Against Glaucoma
6. Rapport International Announces Partnership with SDL
7. MAP International Provides $10 Million in Essential Medicines and Medical Supplies to Haiti Relief
8. Sanford Heart Hospital Physicians Again Recognized Internationally for Innovative Techniques
9. Chances For Children Founder Craig Juntunen Urges International Adoption as Part of the Solution in Aftermath of Haiti Earthquake
10. International Breast Milk Project Delivers Donor Breast Milk to Orphaned and Sick Babies in Haiti
11. AMD Alliance International Announces $10,000 Video Contest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... ... for documenting and diagramming network and data center assets and audio-video devices has ... can request new equipment shapes for free and download shapes and stencils from ...
(Date:3/29/2017)... ... 2017 , ... An inventor from Raynham, Mass., knows the ... conjunction with my braces always rubbed against the inside of my cheeks, causing ... problem." The O.B.S. was the result of his brainstorming. , This patent-pending invention ...
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly of synthetic DNA ... many repetitive steps and often scientists require many different versions of DNA. Therefore, ... results in a lower error rate and cost saving for reagents and consumables. ...
(Date:3/29/2017)... ... 29, 2017 , ... Hamlin Dental Group, multi-location dental office in North ... Dental lasers are safe and effective options, and can be used alone or in ... overall quality of care. , Dr. Hamid Reza of Hamlin Dental Group offers other ...
(Date:3/29/2017)... ... March 29, 2017 , ... Physicians’ Education Resource® (PER®), ... medical education conference for clinicians who manage some of the most difficult-to-treat forms ... , The program will be led by co- chairs Dr. John Marshall, chief ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... March 29, 2017  Experts in the field ... devices like  Soberlink Systems  as a model for ... published in early 2017, concluded that remote blood ... managing patient recovery." The findings of ... Addiction Medicine, detail a range of variables that ...
(Date:3/29/2017)... , March 29, 2017  Glenmark Pharmaceuticals, ... for GSP 301, an investigational fixed-dose combination of ... mcg) administered twice-daily as a nasal spray being ... These results are from a recently completed Phase ... GSP 301 combination therapy versus mometasone, olopatadine or ...
(Date:3/29/2017)... 29, 2017 Research and Markets has announced ... report to their offering. ... The global lifestyle drugs market to grow at a ... report, Global Lifestyle Drugs Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
Breaking Medicine Technology: